© 2022 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
WKAR News

House panel adopts COVID 'right-to-try' bill

Photo of a COVID-19 molecule
Courtesy
/
Canva

The state House Health Policy Committee has approved a bill to allow people to try experimental COVID-19 treatments.

Michigan already has a “right-to-try” law that allows people facing serious illnesses to turn to experimental remedies with a doctor’s approval.

But this bill is different in that it specifically names COVID as a covered illness as long as the treatment has cleared the initial stage of an Food and Drug Administration approval process, says Republican Representative Mary Whiteford who sponsored the measure.

“So, it’s very clear. It’s got to be safe to start with. It just hasn’t advanced in clinical studies to address COVID, specifically,” said Whiteford.

But the bill is opposed by some Democrats, who argue that’s beside the point.

Democratic Representative Laurie Pohutsky said the bill can still be used to provide cover for those who want to prescribe or take questionable treatments such as Ivermectin, which is approved to treat parasitic infections, or hydroxychloroquine, which is an approved anti-malaria drug.

Neither is approved to treat COVID.

“So, a drug can be FDA-approved for something but still not be suitable to treat something else,” said Pohutsky.

She also said the bill appears to be an effort to rationalize the use of a controversial treatments.

“The 'right-to-try' act doesn’t preclude any particular diseases,” Pohutsky said, “So, there’s no reason to specifically name one other than to purposefully feed into a narrative about that illness.”

The bill now goes to the House floor.

News from WKAR will never be behind a paywall. Ever. We need your help to keep our coverage free for everyone. Please consider supporting the news you rely on with a donation today. You can support our journalism for as little as $5. Every contribution, no matter the size, propels our vital coverage. Thank you.